Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.02
+0.02 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
6.02
0.00 (0.00%)
After-hours: Dec 5, 2025, 6:43 PM EST
Coya Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Coya Therapeutics stock ranges from a low of $14 to a high of $18. The average analyst price target of $15.8 forecasts a 162.46% increase in the stock price over the next year.
Price Target: $15.80 (+162.46%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Coya Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +132.56% | Nov 14, 2025 |
| BTIG | BTIG | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +165.78% | Nov 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +149.17% | Nov 12, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +149.17% | Sep 30, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +199.00% | Sep 29, 2025 |
Financial Forecast
Revenue This Year
6.71M
from 3.55M
Increased by 88.66%
Revenue Next Year
102.00K
from 6.71M
Decreased by -98.48%
EPS This Year
-1.20
from -0.98
EPS Next Year
-1.51
from -1.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.3M | 420,000 | ||||
| Avg | 6.7M | 102,000 | ||||
| Low | 3.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 162.4% | -93.7% | ||||
| Avg | 88.7% | -98.5% | ||||
| Low | 9.9% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.04 | -1.35 | ||||
| Avg | -1.20 | -1.51 | ||||
| Low | -1.33 | -1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.